1. Prediction of m6A and m5C at single-molecule resolution reveals a transcriptome-wide co-occurrence of RNA modifications.
- Author
-
Acera Mateos, P, J Sethi, A, Ravindran, A, Srivastava, A, Woodward, K, Mahmud, S, Kanchi, M, Guarnacci, M, Xu, J, W S Yuen, Z, Zhou, Y, Sneddon, A, Hamilton, W, Gao, J, M Starrs, L, Hayashi, R, Wickramasinghe, V, Zarnack, K, Preiss, T, and Burgio, G
- Subjects
RNA modification & restriction ,METHYLCYTOSINE ,RNA sequencing ,ADENOSINES ,TRANSCRIPTOMES - Abstract
The epitranscriptome embodies many new and largely unexplored functions of RNA. A significant roadblock hindering progress in epitranscriptomics is the identification of more than one modification in individual transcript molecules. We address this with CHEUI (CH3 (methylation) Estimation Using Ionic current). CHEUI predicts N6-methyladenosine (m6A) and 5-methylcytosine (m5C) in individual molecules from the same sample, the stoichiometry at transcript reference sites, and differential methylation between any two conditions. CHEUI processes observed and expected nanopore direct RNA sequencing signals to achieve high single-molecule, transcript-site, and stoichiometry accuracies in multiple tests using synthetic RNA standards and cell line data. CHEUI's capability to identify two modification types in the same sample reveals a co-occurrence of m6A and m5C in individual mRNAs in cell line and tissue transcriptomes. CHEUI provides new avenues to discover and study the function of the epitranscriptome. The epitranscriptome holds many unexplored RNA functions, but detecting multiple modifications from one sample remains challenging. Here, authors devise a strategy combining AI and nanopore sequencing to uncover a transcriptome-wide co-occurrence of two modification types in individual RNA molecules. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF